CRM-1 encoded by the worm homolog of vertebrate Crim1, has multiple cysteine-rich (CR) domains with potential bone morphogenetic proteins (BMP) binding activity.
crm-1 mutant displays small body phenotype with decreased ploidy in the hypodermis, a feature opposite to lon mutants. We have previously suggested that
crm-1 controls body size via modulation of
dbl-1/sma activity in the hypodermis and thus endoreduplication, and it functions non-autonomously in facilitating
dbl-1 signaling event. Interestingly, data from the C. elegans Interactome Network showed that CRM-1 interacts with LON-1 in yeast. Would this LON-1 transmembrane protein regulated by BMP signal be able to act extracellularly to antagonize BMP signaling as a feedback circuit to sustain its own effect of blocking endoreduplication? As an alternative, CRM-1 may indirectly facilitate BMP signaling via association of LON-1 and blocks the
lon-1 repression on endoreduplication. To test these hypotheses, characterization of
crm-1 and its interaction with
lon-1 was initiated. Isoforms of
crm-1 were tested for their ability to interact with
lon-1 product. Body length rescue experiments by
crm-1 cDNA isoforms were also conducted to identify functional domains of the CRM-1 protein. At this moment, only the intracellular function of
lon-1 has been documented for repressing endoreduplication in the hypodermis. We will examine the extracellular function of LON-1 by ectopically expressing
lon-1 cDNA in tissues outside the hypodermis. Mutant rescue activities are monitored in these ectopic expression studies to evaluate
lon-1''s potential non-autonomous and autonomous function. Furthermore, the double mutant of
crm-1 and
lon-1 has been constructed, the body length and hypodermal ploidy will be examined to elucidate their genetic relationship. The data from these experiments and the implication will be discussed in this poster. (The study is supported by Research Grants Council, Hong Kong.).